Overview

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to estimate the relative efficacy and assess the safety of CAIV-T compared to TIV.

Phase:

Phase 3

Details

Lead Sponsor:

MedImmune LLC